|
Clinical Utility
The American Diabetes Association (ADA) recommends A1C as
the best test to find out if a patient's blood sugar is under control over
time. The test should be performed every 3 months for insulin-treated
patients, during treatment changes, or when blood glucose is elevated. For
stable patients on oral agents the recommended frequency is at least twice
per year.
The Diabetes Control and Complications Trial (DCCT) and the
United Kingdom Prospective Diabetes Study (UKPDS)
studies showed that the lower the A1C number, the greater the chances to
slow or prevent the development of serious eye, kidney and nerve disease.
The studies also showed that any improvement in A1C levels can potentially
reduce complications.
The ADA recommends that action be taken when A1C results are
over 8%, and considers the diabetes to be under control when the A1C
result is 7% or less. The Helpful Links page of
this site contains several resources to assist you in managing your
patients.
Relationship of A1C to Average Whole Blood and Plasma
Glucose Levels (2)
|
HbA1c % |
Mean Blood Glucose
(mg/dL) |
Average Plasma
Glucose
(mg/dL) |
Interpretation |
|
4 |
61 |
65 |
Non-Diabetic Range |
|
5 |
92 |
100 |
|
6 |
124 |
135 |
|
7 |
156 |
170 |
Target for Diabetes in Control |
|
8 |
188 |
205 |
Action Suggested according ADA guidelines |
|
9 |
219 |
240 |
|
10 |
251 |
275 |
|
11 |
283 |
310 |
|
12 |
314 |
345 |
1.
web.missouri.edu/~diabetes/ngsp/ghbmbg/ghbmbg.htm
2. Diabetes Care 2002;25:275-8 |